Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples